How hard is it to find $24 billion to offset the cost of repealing the medical device tax? As hard as it is “to find a cup of coffee at Starbucks.” That’s according to National Center for Policy Analysis senior fellow John R. Graham, in a Forbes commentary.
Otsuka Pharmaceutical and H. Lundbeck A/S announced Friday that their new medication Rexulti (brexpiprazole) had been approved by the Food and Drug Administration as an adjunctive treatment for major depressive disorder (MDD) and a treament for schizophrenia.
The American Pharmacists Association Foundation has unveiled its new Patient Self-Management Solutions aimed at reducing overall cost of care by approximately $1,000 per person with diabetes per year, improving health outcomes and increasing patient satisfaction.
The National Association of Chain Drug Stores submitted a statement for the House Energy and Commerce Subcommittee on Health hearing titled “Medicaid at 50: Strengthening and Sustaining the Program” emphasizing the role pharmacy plays in providing convenient, accessible, and cost-effective health services to Medicaid beneficiaries.
Over the same time period that multiple outbreaks of measles and whooping cough made headlines around the country, parents’ views on vaccines became more favorable, according to a poll by University of Michigan C.S. Mott Children's Hospital.
In a major victory for the administration of President Barack Obama, the Supreme Court issued on Thursday a 6-3 decision in King v. Burwell, upholding tax credits to help lower income individuals and families buy health insurance.
CVS Health has entered into new clinical affiliations, bringing the total number of clinical collaborations for CVS Health and MinuteClinic to nearly 60 major health systems and healthcare providers across the country.
Aurobindo Pharma Limited has announced that it has received final approval from the U.S. Food and Drug Administration for entacapone tablets USP, 200 mg, the generic equivalent to Comtan Tablets 200 mg.